Shire Dev., LLC v. Watson Pharm., Inc.
135 S. Ct. 1174, 191 L. Ed. 2d 130, 83 U.S.L.W. 3625, 2015 U.S. LEXIS 850
Supreme Court of the United States·Decided January 26, 2015·No. No. 14–206.·Published·Cited by 1 cases
Opinion
On petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit. Petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Federal Circuit for further consideration in light of Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.,574 U.S. ----,
Free access — add to your briefcase to read the full text and ask questions with AI
Shire Dev., LLC v. Watson Pharm., Inc., 135 S. Ct. 1174, 191 L. Ed. 2d 130, 83 U.S.L.W. 3625, 2015 U.S. LEXIS 850 (U.S. 2015).
135 S. Ct. 1174 (Shire Dev., LLC v. Watson Pharm., Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
Shire Development, LLC v. Watson Pharmaceuticals, Inc.
787 F.3d 1359 (Federal Circuit, 2015)